These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18366304)

  • 1. KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
    Chou CC; Lunn CA; Murgolo NJ
    Expert Rev Mol Diagn; 2008 Mar; 8(2):179-87. PubMed ID: 18366304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
    Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
    Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation.
    Shepherd MC; Duffy SM; Harris T; Cruse G; Schuliga M; Brightling CE; Neylon CB; Bradding P; Stewart AG
    Am J Respir Cell Mol Biol; 2007 Nov; 37(5):525-31. PubMed ID: 17585114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.
    Reich EP; Cui L; Yang L; Pugliese-Sivo C; Golovko A; Petro M; Vassileva G; Chu I; Nomeir AA; Zhang LK; Liang X; Kozlowski JA; Narula SK; Zavodny PJ; Chou CC
    Eur J Immunol; 2005 Apr; 35(4):1027-36. PubMed ID: 15770697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
    Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
    J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K
    Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
    Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
    Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
    Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
    Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
    PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels.
    Schmidt J; Friebel K; Schönherr R; Coppolino MG; Bosserhoff AK
    Cell Res; 2010 Nov; 20(11):1224-38. PubMed ID: 20733613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells.
    De Marchi U; Sassi N; Fioretti B; Catacuzzeno L; Cereghetti GM; Szabò I; Zoratti M
    Cell Calcium; 2009 May; 45(5):509-16. PubMed ID: 19406468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
    Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
    Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells.
    Arthur GK; Duffy SM; Roach KM; Hirst RA; Shikotra A; Gaillard EA; Bradding P
    PLoS One; 2015; 10(12):e0145259. PubMed ID: 26689552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological Role of K(+) Channels in the Regulation of T Cell Function].
    Ohya S
    Yakugaku Zasshi; 2016; 136(3):479-83. PubMed ID: 26935090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of water channel aquaporin-4 in experimental autoimmune encephalomyeritis.
    Miyamoto K; Nagaosa N; Motoyama M; Kataoka K; Kusunoki S
    J Neurol Sci; 2009 Jan; 276(1-2):103-7. PubMed ID: 18945445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
    Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
    Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
    Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
    Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
    McNaughton-Smith GA; Burns JF; Stocker JW; Rigdon GC; Creech C; Arrington S; Shelton T; de Franceschi L
    J Med Chem; 2008 Feb; 51(4):976-82. PubMed ID: 18232633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Wang Y; Mei Y; Feng D; Xu L
    J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.
    Brown BM; Pressley B; Wulff H
    Curr Neuropharmacol; 2018; 16(5):618-626. PubMed ID: 28676010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.